Taevas
IndiaMarket Entry & Growth in India
India is the world's third-largest pharmaceutical market and a fast-growing hub for medical devices and nutraceuticals. Taevas provides end-to-end regulatory, commercial, and distribution support so life-sciences brands can enter and scale with confidence
CDSCO Registered
GMP Certified
ISO 13485
$50B+
Healthcare Market Size
#3
Global Pharma Market Rank
1.4B+
Population
28+
States & Union Territories
Industries We Support
Four Industries. One India Team.
Select an industry to see regulatory pathways, services, and how Taevas supports your India market entry.
Medical Devices & Equipment
Central Drugs Standard Control Organisation (CDSCO)
India's medical devices market is projected to reach $50 billion by 2030, driven by rising chronic disease burden and expanding hospital infrastructure. Under the Medical Devices Rules 2017, all devices must be classified and registered with CDSCO before import or sale. Taevas navigates Class A through D classifications, import licences, and post-market surveillance requirements on behalf of foreign manufacturers.
Regulatory Pathways
Mandatory
Device Classification & Registration
All medical devices sold in India must be classified under Class A, B, C, or D and registered with CDSCO. Taevas prepares and submits the complete technical dossier including performance data, safety evidence, and labelling.
Mandatory
Import Licence (Form MD-14/15)
Foreign manufacturers require an import licence issued by CDSCO before goods can clear Indian customs. Taevas acts as the authorised India agent and manages the Form MD-14 or MD-15 application end to end.
Mandatory
Authorised Indian Representative (AIR)
CDSCO mandates that every overseas manufacturer appoint an Authorised Indian Representative to liaise with the regulator. Taevas serves as AIR, providing a registered local address and ongoing regulatory correspondence.
Ongoing
Post-Market Surveillance & Vigilance
Registered devices are subject to ongoing adverse event reporting and periodic safety updates under MDR 2017. Taevas maintains vigilance systems and submits required reports to CDSCO on your behalf.
Our Services for Medical Devices in India
07
KOL Management
Mapping and engagement of key opinion leaders across cardiology, orthopaedics, diagnostics, and other priority specialties to build clinical credibility for your device.
Why Taevas India
Why Global Brands Choose Taevas for India
Taevas combines deep CDSCO regulatory expertise with an established commercial network spanning all major Indian states, giving life-sciences companies a single trusted partner from registration to revenue.
Regulatory
CDSCO Regulatory Expertise
Our India regulatory team has hands-on experience with CDSCO submissions for medical devices, pharmaceuticals, and cosmetics, reducing approval timelines and minimising query cycles. We stay current with every rule amendment and guidance update from the Drugs Controller General of India.
Coverage
Pan-India Market Reach
Taevas operates across all 28 states and 8 union territories, with distributor relationships spanning metro cities, Tier 2 cities, and emerging rural healthcare markets. Our network gives your brand genuine national coverage from day one.
Speed
Accelerated Time to Market
Our proven India market entry playbook compresses typical registration and launch timelines by identifying the fastest compliant pathways, pre-empting regulatory queries, and activating commercial channels in parallel with regulatory processes.
Networks
Established Distributor & KOL Networks
We maintain active relationships with national and regional distributors, hospital procurement teams, and key opinion leaders across cardiology, oncology, orthopaedics, dermatology, and nutrition specialties throughout India.
Local Team
Dedicated India In-Country Team
Our India team includes regulatory affairs specialists, medical science liaisons, commercial managers, and logistics coordinators who are permanently based in India and available to clients in local time zones.
Experience
Proven Multi-Industry Track Record
Taevas has successfully supported market entries across medical devices, pharmaceuticals, personal care, and food and dietary supplements in India, giving us cross-category insight that benefits every new client engagement.
Get Started
Ready to Enter the India Market?
Speak with our India market entry specialists to receive a tailored regulatory and commercial roadmap for your product category, with clear milestones and realistic timelines.
Free India assessment
CDSCO and FSSAI regulatory specialists
Pan-India distributor network access
End-to-end to revenue